Request for Covid-19 Impact Assessment of this Report

Take Action
Healthcare

Global Immune Repertoire Sequencing Market Size study, by Type (Assay Kits, Software & Services), by Application (Biomarker Discovery, Infectious Diseases, Vaccine Development & Efficacy, Cancer Immunotherapy, Autoimmune Diseases, Transplant Rejection & Tolerance, Others), by End-User (Academic Institutes, Research Center Diagnostic Laboratories, Others) and Regional Forecasts 2018-2025

  • BIZ2908310
  • 200 Pages
  • February 2019
  • Healthcare
Download Sample    Get Discount   
 
Global Immune Repertoire Sequencing Market to reach USD XX billion by 2025.

Global Immune Repertoire Sequencing Market valued approximately USD XX billion in 2017 is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. Immune repertoire is sub-type of proteins on organism’s immune system creates. Immune repertoire sequencing allows scientist and researchers to inspect and recognize the adoptive immune-mediated diseases. Immune repertoire sequencing is also widely accepted in cancer immunotherapy, biomarker discovery, asthma and allergy research and infectious diseases research. Increasing research & development, increasing prevalence of cancer and new launches of novel products are the driving factors of the immune repertoire sequencing market across the globe. In addition, increasing international collaboration in immune repertoire sequencing projects is creating a numerous opportunity in the market over the upcoming years. However, lack of awareness about the about the cancer diseases treatment and high cost related with sequencing platform & data analytics services are the restraining factor of the market across the globe.

The regional analysis of Global Immune Repertoire Sequencing Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to increasingly focus on developing novel technologies and high presence of key players in the region. Europe is also estimated to grow in market due to rapid growth in immune repertoire sequencing in the region over the forecast period. Asia-Pacific is also anticipated to exhibit higher growth rate / CAGR over the forecast period 2018-2025 due to increasing usage of immune repertoire sequencing in oncology research in the region. High prevalence of infectious diseases is substantial driver for growth of immune repertoire sequencing market in Middle East and Africa.

The market player included in this report are:

• Illumina Inc.

• Pacific Biosciences of California Inc.

• Agilent Technologies

• Oxford Nanopore Technologies Ltd.

• QIAGEN N.V.

• Thermo Fischer Scientific

• Hoffmann-La Roche Ltd.

• BGI

• Takara Bio Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

? Assay Kits

? Software & Services

By Application:

? Biomarker Discovery

? Infectious Diseases

? Vaccine Development & Efficacy

? Cancer Immunotherapy

? Autoimmune Diseases

? Transplant Rejection & Tolerance

? Others

By End-User:

? Academic Institutes

? Research Center Diagnostic Laboratories

? Others

By Regions:

? North America

o U.S.

o Canada

? Europe

o UK

o Germany

? Asia Pacific

o China

o India

o Japan

? Latin America

o Brazil

o Mexico

? Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015, 2016

Base year – 2017

Forecast period – 2018 to 2025

Target Audience of the Global Immune Repertoire Sequencing Market in Market Study:

? Key Consulting Companies & Advisors

? Large, medium-sized, and small enterprises

? Venture capitalists

? Value-Added Resellers (VARs)

? Third-party knowledge providers

? Investment bankers

? Investors

TABLE OF CONTENTS

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Key Trends

1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)

1.3.1. Immune Repertoire Sequencing Market, by Type, 2015-2025 (USD Billion)

1.3.2. Immune Repertoire Sequencing Market, by Application, 2015-2025 (USD Billion)

1.3.3. Immune Repertoire Sequencing Market, by End-User, 2015-2025 (USD Billion)

1.3.4. Immune Repertoire Sequencing Market, by Region, 2015-2025 (USD Billion)

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Immune Repertoire Sequencing Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Industry Evolution

2.2.2. Scope of the Study

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Immune Repertoire Sequencing Market Dynamics

3.1. See Saw Analysis

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Immune Repertoire Sequencing Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Buyers

4.1.2. Bargaining Power of Suppliers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model

4.2. PEST Analysis

4.2.1. Political Scenario

4.2.2. Economic Scenario

4.2.3. Social Scenario

4.2.4. Technological Scenario

4.3. Value Chain Analysis

4.3.1. Supplier

4.3.2. Manufacturers/Service Provider

4.3.3. Distributors

4.3.4. End-Users

4.4. Key Buying Criteria

4.5. Regulatory Framework

4.6. Cost Structure Analysis

4.6.1. Raw Material Cost Analysis

4.6.2. Manufacturing Cost Analysis

4.6.3. Labor Cost Analysis

4.7. Investment Vs Adoption Scenario

4.8. Analyst Recommendation & Conclusion

Chapter 5. Immune Repertoire Sequencing Market, by Type

5.1. Market Snapshot

5.2. Market Performance - Potential Model

5.3. Key Market Players

5.4. Immune Repertoire Sequencing Market, Sub Segment Analysis

5.4.1. Assay Kits

5.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.4.2. Software & Services

5.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 6. Immune Repertoire Sequencing Market, by Application

6.1. Market Snapshot

6.2. Market Performance - Potential Model

6.3. Key Market Players

6.4. Immune Repertoire Sequencing Market, Sub Segment Analysis

6.4.1. Biomarker Discovery

6.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.4.2. Infectious Diseases

6.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.4.3. Vaccine Development and Efficacy

6.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.4.4. Cancer Immunotherapy

6.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.4.5. Autoimmune Diseases

6.4.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.4.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.4.6. Transplant Rejection and Tolerance

6.4.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.4.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.4.7. Others

6.4.7.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.4.7.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 7. Immune Repertoire Sequencing Market, by End-User

7.1. Market Snapshot

7.2. Market Performance - Potential Model

7.3. Key Market Players

7.4. Immune Repertoire Sequencing Market, Sub Segment Analysis

7.4.1. Academic Institutes

7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.2. Research Centers Diagnostic Laboratories

7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.3. Others

7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 8. Immune Repertoire Sequencing Market, by Regional Analysis

8.1. Immune Repertoire Sequencing Market, Regional Market Snapshot (2015-2025)

8.2. North America Immune Repertoire Sequencing Market Snapshot

8.2.1. U.S.

8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.2.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.2. Canada

8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.2.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3. Europe Immune Repertoire Sequencing Market Snapshot

8.3.1. U.K.

8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.2. Germany

8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.3. France

8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.4. Rest of Europe

8.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.4.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.4.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4. Asia Immune Repertoire Sequencing Market Snapshot

8.4.1. China

8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.2. India

8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.3. Japan

8.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.3.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.4. Rest of Asia Pacific

8.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.4.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.4.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5. Latin America Immune Repertoire Sequencing Market Snapshot

8.5.1. Brazil

8.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.5.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.2. Mexico

8.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.5.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6. Rest of The World

8.6.1. South America

8.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.6.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.2. Middle East and Africa

8.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.6.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 9. Competitive Intelligence

9.1. Company Market Share (Subject to Data Availability)

9.2. Top Market Strategies

9.3. Company Profiles

9.3.1. Illumina Inc.

9.3.1.1. Overview

9.3.1.2. Financial (Subject to Data Availability)

9.3.1.3. Product Summary

9.3.1.4. Recent Developments

9.3.2. Pacific Biosciences of California Inc.

9.3.3. Agilent Technologies

9.3.4. Oxford Nanopore Technologies Ltd.

9.3.5. QIAGEN N.V.

9.3.6. Thermo Fischer Scientific

9.3.7. Hoffmann-La Roche Ltd.

9.3.8. BGI

9.3.9. Takara Bio Inc.

Chapter 10. Research Process

10.1. Research Process

10.1.1. Data Mining

10.1.2. Analysis

10.1.3. Market Estimation

10.1.4. Validation

10.1.5. Publishing

10.1.6. Research Assumption

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF IMMUNE REPERTOIRE SEQUENCING MARKET

TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF IMMUNE REPERTOIRE SEQUENCING MARKET

TABLE 3. IMMUNE REPERTOIRE SEQUENCING MARKET, REPORT SCOPE

TABLE 4. YEARS CONSIDERED FOR THE STUDY

TABLE 5. EXCHANGE RATES CONSIDERED

TABLE 6. IMMUNE REPERTOIRE SEQUENCING MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD BILLION)

TABLE 7. IMMUNE REPERTOIRE SEQUENCING MARKET ESTIMATES & FORECASTS BY COMPONENT 2015-2025 (USD BILLION)

TABLE 8. IMMUNE REPERTOIRE SEQUENCING MARKET ESTIMATES & FORECASTS BY TYPE 2015-2025 (USD BILLION)

TABLE 9. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 10. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 11. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 12. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 13. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 14. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 15. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 16. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 17. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 18. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 19. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 20. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 21. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 22. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 23. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 24. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 25. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 26. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 27. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 28. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 29. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 30. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 31. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 32. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 33. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 34. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 35. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 36. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 37. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 38. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 39. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 40. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 41. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 42. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 43. IMMUNE REPERTOIRE SEQUENCING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 44. IMMUNE REPERTOIRE SEQUENCING MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 45. U.S. IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 46. U.S. IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 47. U.S. IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 48. U.S. IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 49. U.S. IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 50. CANADA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 51. CANADA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 52. CANADA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 53. CANADA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 54. CANADA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 55. UK IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 56. UK IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 57. UK IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 58. UK IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 59. UK IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 60. GERMANY IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 61. GERMANY IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 62. GERMANY IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 63. GERMANY IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 64. GERMANY IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 65. ROE IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 66. ROE IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 67. ROE IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 68. ROE IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 69. ROE IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 70. CHINA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 71. CHINA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 72. CHINA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 73. CHINA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 74. CHINA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 75. INDIA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 76. INDIA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 77. INDIA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 78. INDIA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 79. INDIA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 80. JAPAN IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 81. JAPAN IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 82. JAPAN IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 83. JAPAN IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 84. JAPAN IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 85. ROAPAC IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 86. ROAPAC IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 87. ROAPAC IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 88. ROAPAC IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 89. ROAPAC IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 90. BRAZIL IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 91. BRAZIL IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 92. BRAZIL IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 93. BRAZIL IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 94. BRAZIL IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 95. MEXICO IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 96. MEXICO IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 97. MEXICO IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 98. MEXICO IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 99. MEXICO IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 100. ROLA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 101. ROLA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 102. ROLA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 103. ROLA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 104. ROLA IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 105. ROW IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 106. ROW IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 107. ROW IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 108. ROW IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 109. ROW IMMUNE REPERTOIRE SEQUENCING MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Digital Pathology Market by Product (Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage & Communication, Digital IVD Devices, and Others [Telepathology]), Type (Automated Hematology Analyzers & Blood Cell Counters, Chromosome Analyzers, FISH Enumeration Systems, Urine Sediment Analyzers, Immunohistochemistry Image Analysis Applications, Digital Cytopathology, Digital PCR, Signet Cell Detection, and Digital Holographic Microscopy), and End User (Educational, Clinical, and Pharma & Biotech Companies) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...

  • Publish Date: February 26, 2018
  • $5370
View Details
Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
View Details
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research